Xing Z, Kang N, Lin Y, Zhou X, Xiao Z, Cao D
BMC Med Imaging. 2020; 20(1):62.
PMID: 32517711
PMC: 7285432.
DOI: 10.1186/s12880-020-00462-7.
Baek D, Cho H, Bae J, Sohn S, Moon J
Blood Res. 2020; 55(2):99-106.
PMID: 32408414
PMC: 7343555.
DOI: 10.5045/br.2020.2020032.
You H, Baluszek S, Kaminska B
Theranostics. 2020; 10(7):2949-2964.
PMID: 32194848
PMC: 7053204.
DOI: 10.7150/thno.40783.
You H, Baluszek S, Kaminska B
Front Immunol. 2019; 10:1941.
PMID: 31481958
PMC: 6710386.
DOI: 10.3389/fimmu.2019.01941.
Grommes C, Nayak L, Tun H, Batchelor T
Neuro Oncol. 2018; 21(3):306-313.
PMID: 30423172
PMC: 6380407.
DOI: 10.1093/neuonc/noy193.
Craniotomy and Survival for Primary Central Nervous System Lymphoma.
Rae A, Mehta A, Cloney M, Kinslow C, Wang T, Bhagat G
Neurosurgery. 2018; 84(4):935-944.
PMID: 29660011
PMC: 6500886.
DOI: 10.1093/neuros/nyy096.
Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.
Strehlow F, Bauer S, Martus P, Weller M, Roth P, Schlegel U
J Neurooncol. 2016; 129(1):165-71.
PMID: 27294357
DOI: 10.1007/s11060-016-2162-5.
Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma.
Yushi Q, Li Z, von Roemeling C, Doeppler H, Marlow L, Kim B
Oncotarget. 2016; 7(22):32156-71.
PMID: 27050077
PMC: 5078004.
DOI: 10.18632/oncotarget.8537.
T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Presenting as a Primary Central Nervous System Lymphoma.
Advani P, Starr J, Swaika A, Jiang L, Qiu Y, Li Z
Rare Tumors. 2016; 7(4):6084.
PMID: 26788280
PMC: 4703926.
DOI: 10.4081/rt.2015.6084.
The Role of Lymphocyte to Monocyte Ratio, Microvessel Density and HiGH CD44 Tumor Cell Expression in Non Hodgkin Lymphomas.
Jelicic J, Todorovic Balint M, Perunicic Jovanovic M, Boricic N, Micev M, Stojsic J
Pathol Oncol Res. 2016; 22(3):567-77.
PMID: 26750138
DOI: 10.1007/s12253-015-0032-7.
The histological classification of diffuse large B-cell lymphomas.
Xie Y, Pittaluga S, Jaffe E
Semin Hematol. 2015; 52(2):57-66.
PMID: 25805585
PMC: 4374126.
DOI: 10.1053/j.seminhematol.2015.01.006.
Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma.
He M, Zuo C, Wang J, Liu J, Jiao B, Zheng J
Neuro Oncol. 2013; 15(6):727-34.
PMID: 23482670
PMC: 3661096.
DOI: 10.1093/neuonc/not012.
The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification.
Menon M, Pittaluga S, Jaffe E
Cancer J. 2012; 18(5):411-20.
PMID: 23006945
PMC: 3458515.
DOI: 10.1097/PPO.0b013e31826aee97.
Primary central nervous system B cell lymphoma with features intermediate between diffuse large B cell lymphoma and Burkitt lymphoma.
Jiang L, Li Z, Finn L, Personnet D, Edenfield B, Foran J
Int J Clin Exp Pathol. 2012; 5(1):72-6.
PMID: 22295149
PMC: 3267488.
Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.
Wieduwilt M, Valles F, Issa S, Behler C, Hwang J, McDermott M
Clin Cancer Res. 2012; 18(4):1146-55.
PMID: 22228634
PMC: 3288204.
DOI: 10.1158/1078-0432.CCR-11-0625.
Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification.
Jaffe E, Pittaluga S
Hematology Am Soc Hematol Educ Program. 2011; 2011:506-14.
PMID: 22160082
PMC: 6329301.
DOI: 10.1182/asheducation-2011.1.506.
Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.
Chan C, Rubenstein J, Coupland S, Davis J, Harbour J, Johnston P
Oncologist. 2011; 16(11):1589-99.
PMID: 22045784
PMC: 3233294.
DOI: 10.1634/theoncologist.2011-0210.
YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma.
Hottinger A, Iwamoto F, Karimi S, Riedel E, Dantis J, Park J
Ann Neurol. 2011; 70(1):163-9.
PMID: 21391238
PMC: 7295085.
DOI: 10.1002/ana.22360.
Selective central nervous system tropism of primary central nervous system lymphoma.
Jiang L, Marlow L, Cooper S, Roemeling C, Menke D, Copland J
Int J Clin Exp Pathol. 2010; 3(8):763-7.
PMID: 21151389
PMC: 2993226.
Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma.
Barajas Jr R, Rubenstein J, Chang J, Hwang J, Cha S
AJNR Am J Neuroradiol. 2009; 31(1):60-6.
PMID: 19729544
PMC: 3376760.
DOI: 10.3174/ajnr.A1750.
